Prenetics Global (PRE) Net Income towards Common Stockholders (2021 - 2025)
Prenetics Global (PRE) reported Net Income towards Common Stockholders of -$31.3 million for Q4 2025, down 644.5% year-over-year from $5.7 million in Q4 2024, and down 1542.2% quarter-over-quarter from -$1.9 million in Q3 2025.
Prenetics Global (PRE) Net Income towards Common Stockholders (2021 - 2025) Analysis & Trends
Prenetics Global (PRE) has 5 years of Net Income towards Common Stockholders data on file, last reported at -$31.3 million in Q4 2025.
- Net Income towards Common Stockholders for Q4 2025 came in at -$31.3 million, down 644.5% year-over-year; the trailing twelve-month figure through Dec 2025 was -$37.2 million (down 328.15% YoY), and the FY2025 annual result was -$37.7 million, up 18.56% from the prior year.
- Net Income towards Common Stockholders declined to -$31.3 million in Q4 2025 per PRE's latest filing, from -$1.9 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $14.7 million in Q4 2022 and troughed at -$144.2 million in Q2 2022.
- A 5-year average of -$21.2 million and a median of -$3.2 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders jumped 116.62% in 2022, then sank 7948.15% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$88.5 million in 2021, then jumped by 116.62% to $14.7 million in 2022, then slumped by 106.98% to -$1.0 million in 2023, then slumped by 309.16% to -$4.2 million in 2024, then plunged by 644.5% to -$31.3 million in 2025.
- Business Quant data shows PRE's Net Income towards Common Stockholders at -$31.3 million in Q4 2025, -$1.9 million in Q3 2025, and -$1.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 141.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Prenetics Global | 520,750.00 | -62.80 Mn | 21.74 Mn | -31.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.28 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | -2.17 Mn |
| Dec 31, 2024 | -4.20 Mn |
| Sep 30, 2024 | -2.20 Mn |
| Jun 30, 2024 | -2.25 Mn |
| Mar 31, 2024 | -27,000.00 |
| Dec 31, 2023 | -1.03 Mn |
| Sep 30, 2023 | -2.09 Mn |
| Jun 30, 2023 | -22.21 Mn |
| Mar 31, 2023 | -10.97 Mn |
| Dec 31, 2022 | 14.71 Mn |
| Sep 30, 2022 | -14.90 Mn |
| Jun 30, 2022 | -144.18 Mn |
| Mar 31, 2022 | -29.65 Mn |
| Dec 31, 2021 | -88.49 Mn |
| Sep 30, 2021 | -80.41 Mn |
| Jun 30, 2021 | -4.94 Mn |
| Mar 31, 2021 | 5.60 Mn |